Moreno Evelyn V Bristol Myers Squibb CO Transaction History

Moreno Evelyn V

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $2.03 Million - $2.27 Million	-35,032 Reduced 46.99%	39,527 $2.29 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $663,539 - $736,757	-10,415 Reduced 12.26%	74,559 $4.77 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $568,851 - $645,206	8,657 Added 11.34%	84,974 $5.89 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $2.54 Million - $3.01 Million	37,116 Added 94.68%	76,317 $5.49 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $4,049 - $2.39 Million	-31,151 Reduced 44.28%	39,201 $2.79 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $4.83 Million - $5.32 Million	66,565 Added 1757.72%	70,352 $5.42 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $232,824 - $279,177	3,787 New	3,787 $277,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Moreno Evelyn V, based on Form 13F filings with the SEC.

Stay updated on Moreno Evelyn V with notifications on news.